BIOASTER announces a collaboration with Exeliom Biosciences, a leading biotech in the developement of innovative microbiome-based therapies, located in Paris and Dijon, France. The aim of the partnership is to strengthen Exeliom Biosciences’ production pipeline. It will rely on BIOASTER’s expertise and proprietary ANOXIC platform to measure the viability and cultivability of Extremely Oxygen Sensitive species.
Find out more about the BIOASTER ANOXIC platform: https://youtu.be/VaD6XuviD8E